NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)

NCT01092858 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism

Interventions

DRUG: Testosterone Undeconate (Nebido, BAY86-5037)
DRUG: Placebo

Sponsor

Bayer